Vilin Bio Med Ltd Financials
Company Logo

Vilin Bio Med Ltd Financial Statement

Vilin Bio Med Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2023
Revenue3.30
Operating Expense3.06
Net Profit-0.04
Net Profit Margin-1.21
Earning Per ShareTBA
EBIDTA0.24
Effective Tax Rate29.17

Vilin Bio Med Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual15.80
Operating Expenses Annual14.99
Operating Profit Annual1.14
Interest Annual0.79
Depreciation0.13
Net Profit Annual0.16
Tax Annual0.06

Vilin Bio Med Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.03
Cash Flow from Operations-5.30
Cash Flow from Investing0.32
Cash Flow from Financing10.99
Cash Flow at the End6.05

Vilin Bio Med Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)7.28
PBIT Margin (%)6.46
PBT Margin (%)-1.64
Net PROFIT Margin (%)1.01
Return On Networth / Equity (%)0.95
Return On Networth /Employed (%)4.46
Return On Assets (%)0.71
Total Debt / Equity (X)0.35
Asset Turnover Ratio (%)0.70

Vilin Bio Med Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1.38
Total Current Assets Annual18.62
Non Current Assets Annual13.79
Total Shareholders Funds Annual22.84
Total Assets Annual32.40

Vilin Bio Med Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Oct 8, 2024, Vilin Bio Med Ltd has a market capitalization of 26.51 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Vilin Bio Med Ltd is debt-free with a debt-to-equity ratio of 0.30.
In FY 2023 , Vilin Bio Med Ltd recorded a total revenue of approximately 15.80 Cr marking a significant milestone in the company's financial performance.
Vilin Bio Med Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..
Vilin Bio Med Ltd's current PE ratio is 165.69.
Vilin Bio Med Ltd's ROCE averaged 7.8% from the FY ending March 2022 to 2024, with a median of 4.3%. It peaked at 15.6% in March 2023, reflecting strong capital efficiency over the period..
Vilin Bio Med Ltd's latest EBIT is Rs. 1.02 Cr, surpassing the average EBIT of Rs. 1.33 Cr over the 5 years..